Skip to content

Daclatasvir Impurity L

Daclatasvir Impurity L

Product Description
CAT No.
ALN-D036034
CAS No.
787-69-9
Mol. F.
C16H14O2
Mol. Wt.
238.3
Stock
Please Inquire
RFQ
Chemical Name : 1,1′-([1,1′-Biphenyl]-4,4′-diyl)bis(ethan-1-one)
Smiles : O=C(C)C1=CC=C(C=C1)C2=CC=C(C(C)=O)C=C2
Inchi : InChI=1S/C41H52N8O6/c1-7-25(4)35(47-41(53)55-6)39(51)49-21-9-11-33(49)37-43-23-31(45-37)29-18-14-27(15-19-29)26-12-16-28(17-13-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(2)3)46-40(52)54-5/h12-19,22-25,32-35H,7-11,20-21H2,1-6H3,(H,42,44)(H,43,45)(H,46,52)(H,47,53)/t25-,32-,33-,34-,35-/m0/s1
Synonym : Di-p-acetylbiphenyl

A validated stability-indicating reverse-phase high-performance liquid chromatography method for daclatasvir, identification and characterization of degradation products using LC-ESI-QTOF-MS

By Warghade, Snehal V.; Bothara, Kailash G.nFrom Asian Journal of Pharmaceutical and Clinical Research (2019), 12(5), 302-308

Development and validation of HPLC fluorescence and UPLC/DAD stability-indicating methods for determination of hepatitis C antiviral agent daclatasvir

By Kamal, Andra H.; Ismail, Nahla S.; Mabroijk, Mokhtar M.; Bebawy, Lories I.; Mekky, Mai A. – From Journal of AOAC International (2019), 102(4), 1125-1131

A stability-indicating UPLC method for the determination of potential impurities and its mass by a new QDa mass detector in daclatasvir drug used to treat hepatitis C infection

By Jagadabi, Varaprasad; Kumar, P. V. Nagendra; Mahesh, Kasthuri; Pamidi, Srinivasu; Ramaprasad, L. A.; Nagaraju, D. – From Journal of Chromatographic Science (2019), 57(1), 44-53

Request For Quotation

Related Products